Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Erectile Dysfunction × Erythropoietin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Myelodysplastic Syndromes 1 Leukemia, Myelomonocytic, Chronic 1 Head and Neck Neoplasms 1 Erectile Dysfunction 1

Interventions

udenafil 1 mirabegron 1 bicalutamide 1 alpha-Tocopherol 1 Vitamin E 1 Tamoxifen 1 Tadalafil 1 Sildenafil Citrate 1 Pentoxifylline 1 Long-Term Synaptic Depression 1 GPI 1485 1 Erythropoietin 1 Dutasteride 1 Atorvastatin 1 Arginine 1 ArginMax 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00737893 2021-04-08

ERECT

Johns Hopkins University

Phase 2 Completed

56 enrolled 27 charts

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡